Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas-Reference-Cited by-同舟云学术

Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas

Published:2018-11-13 Issue:24 Volume:124 Page:4650-4656
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ahvenainen Terhi V.¹²^ORCID,Mäkinen Netta M.¹²,von Nandelstadh Pernilla¹²,Vahteristo Maija E. A.¹²,Pasanen Annukka M.³,Bützow Ralf C.³,Vahteristo Pia M.¹²

Affiliation:

1. Genome‐Scale Biology Research Program, Research Programs UnitUniversity of Helsinki Helsinki Finland

2. Department of Medical and Clinical Genetics, MedicumUniversity of Helsinki Helsinki Finland

3. Department of PathologyLaboratory of Helsinki University Central Hospital, Helsinki University Central Hospital and Medicum, University of Helsinki Helsinki Finland

Funder

Syöpäjärjestöt

Sigrid Juséliuksen Säätiö

Academy of Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31754

Reference24 articles.

1. Uterine Fibroids

2. MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

3. Genomics of uterine leiomyomas: insights from high-throughput sequencing

4. WHO Classification of Tumours of Female Reproductive Organs 2014 IARC Press Lyon France E Oliva M Carcangiu S Carinelli RJ Kurman ML Carcangiu CS Herrington RH Young Mesenchymal tumours 135 138

5. MED12 exon 2 mutations in histopathological uterine leiomyoma variants

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular basis of uterine mesenchymal tumours;Diagnostic Histopathology;2024-09

2. Metastatic Leiomyoma With Malignant Transformation Harboring RAB2A-PLAG1 Fusion—A Case Report and Review With Molecular Analysis;International Journal of Gynecological Pathology;2024-07-29

3. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas;International Journal of Medical Sciences;2024

4. The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia;Cancers;2023-10-26

5. Benign Metastasizing Leiomyoma: Is “Wait and Watch” Strategy Feasible?;Reproductive Sciences;2023-08-02